Revascularization decreases 8-isoprostaglandin F2α excretion in chronic lower limb ischemia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 71, Issue 2, 2004, Pages 97-101

  Rossi, P ^a   Riutta, A ^b   Kuukasjarvi P ^c   Vehmas, T ^b   Mucha, I ^d   Salenius, J P ^c  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d Institute of Isotopes   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMOROFEMORAL BYPASS; FEMOROPOPLITEAL BYPASS; HUMAN; LEG ISCHEMIA; MALE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVASCULARIZATION; STENOSIS; URINALYSIS;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DINOPROST; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; OXIDATIVE STRESS; RADIOIMMUNOASSAY;

ANIMALIA;

EID: 3042713553     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.01.003     Document Type: Article

References (31)

1. Patrono C., FitzGerald G.A. Isoprostanes. potential markers of oxidant stress Arterioscler. Thromb. Vasc. Biol. 17:1997;2309-2315
2. Pratico D., Barry O.P., Lawson J., Adiyaman M., Huang S.-W., Khanapure H., Rokach J., FitzGerald G.A. IPF2a-1. an index of lipid peroxidation in humans Proc. Natl. Acad. Sci. USA. 95:1998;3449-3454
3. Roberts L.J. II, Morrow J.D. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free. Radic. Biol. Med. 28:2000;505-513
4. Pratico D., Lawson J.A., Rokach J., FitzGerald G.A. The isoprostanes in biology medicine. Trends Endocrinol. Metab. 12:2001;243-247
5. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. II A series of prostaglandin F2-like compounds are produced in vivo by a non-cyclooxygenase, free radical-catalysed mechanism. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387
6. Wang Z., Ciabattoni G., Creminon C., Lawson J., FitzGerald G.A., Patrono C., Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2alpha excretion in man. J. Pharmacol. Exp. Ther. 275:1995;94-100
7. Takahashi K., Nammour T.M., Fukunaga M., Ebert J., Morrow J.D., Roberts L.J., Hoover R.L., Badr K. Glomerular actions of a free radical-generated novel prostaglandin, 8-isoprostaglandin F2α in the rat. evidence for interaction with thromboxane A2 receptors J. Clin. Invest. 90:1992;136-141
8. Pratico D., Smyth E.M., Violoi F., FitzGerald G.A. Local amplification of platelet function by 8-epiprostaglandin F2á is not mediated by thromboxane receptor isoforms. J. Biol. Chem. 271:1996;14916-14924
9. Minuz P., Andrioli G., Degan M., Gaino S., Ortolani R., Tommasoli R., Zuliani V., Lechi A., Lechi C. The F2-isoprostane 8-epiprostaglandin F2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler. Thromb. Vasc. Biol. 18:1998;1248-1256
10. Cracowski J.-L., Durand T., Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans. physiology pharmacology, and clinical implications Trends Pharmacol. Sci. 23:2002;360-366
11. Fontana L., Giaculli C., Minuz P., Lechi A., Laudanna V. 8-iso PGF2α induces β2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils. A link between oxidative stress and ischaemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 21:2001;55-60
12. Zahler S., Becker B.F. Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2α-III and iPE2-III). Prostaglandins Lipid Mediators. 57:1999;319-331
13. Janssen L.J. Isoprostanes. an overview and putative roles in pulmonary pathophysiology Am. J. Physiol. 280:2001;L1067-L1082
14. Chiabrando C., Valagussa A., Rivalta C., Durand T., Guy A., Zuccato E., Villa P., Rossi J.-C., Fanelli R. Identification and measurement of endogeneous β-oxidation metabolites of 8-epi-prostaglandin F2α J. Biol. Chem. 274:1999;1313-1319
15. Morrow J.D., Badr K., Roberts L.J. II Evidence that the F2-isoprostane, 8-epi- PGF2α, is formed in vivo. Biochim. Biophys. Acta. 1210:1994;244-248
16. Delanty N., Reilly M.P., Pratico D., Lawson J.A., McCarthy J.F., Wood A.E., Ohnishi S.T., FitzGerald D.J., FitzGerald G.A. 8-epi-PGF2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation. 95:1997;2492-2499
17. Helmersson J., Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot. Essent. Fatty Acids. 61:1999;203-205
18. Goldman G., Welbourn R., Klausner J.M., Valeri C.R., Shepro D., Hectman H.B. Oxygen free radicals are required for ischemia-induced leukotriene B4 synthesis and diapedesis. Surgery. 111:1992;287-293
19. Reilly M.P., Muredach P., Delanty N., Roy L., Rokach J., Callaghan P.O., Crean P., Lawson J.A., FitzGerald G.A. Increased formation of IPF2α-I and 8-epi- prostaglandin F2α in acute coronary angioplasty. evidence for oxidant stress during coronary reperfusion in humans Circulation. 96:1997;3314-3320
20. Iuliano L., Pratico D., Greco C., Mangieri E., Scibilia G., FitzGerald G.A., Violi F. Angioplasty increases coronary sinus F2-isoprostane formation. evidence for in vivo oxidative stress during PTCA J. Am. Coll. Cardiol. 37:2001;289-290
21. Rodbard D. Statistical control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin. Chem. 20:1974;1255-1270
22. De Caterina R., Cipollone F., Filardo F.P., Zimarino M., Bernini W., Lazzerini G., Bucciarelli T., Falco A., Marchesani P., Muraro R., Mezzetti A., Ciabattoni G. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects. No further effect of vitamin E. Circulation. 106:2002;2543-2549
23. Pratico D., Basili S., Vieri M., Cordova C., Violi F., FitzGerald G.A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2α-III, an index of oxidant stress. Am. J. Resp. Crit. Care Med. 158:1998;1709-1714
24. Belton O., Byrne D., Kearnye D., Leahy A., FitzGerald D.J. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation. 102:2000;840-845
25. Oguogho A., Kritz H., Wagner O., Sinzinger H. 6-oxo-PGF1-alpha and 8-epi- PGF2-alpha in the arterial wall layers of various species. a comparison between intact and atherosclerotic areas Prostaglandins Leukot. Essent. Fatty Acids. 64:2001;167-171
26. Pratico D., Iuliano L., Mauriello A., Spagnoli L., Lawson J.A., Maclouf J. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 100:1997;2028-2034
27. Paterson I.S., Klausner J.M., Goldman G., Kobzik L., Welbourn R., Valweri C.R., Shepro D., Hechtmann H.B. Thromboxane mediates the ischemia-induced neutrophil oxidative burst. Surgery. 106:1989;224-229
28. Oredsson S., Qvarfordt P., Plate G. Polymorphonuclear leucocytes increase reperfusion injury in skeletal muscle. Int. Angiol. 14:1995;80-88
29. Crinnion J.N., Homer-Vanniasinkam S., Parkin S.M., Gough M.J. Role of neutrophil-adhesion in skeletal muscle reperfusion injury. Br. J. Surg. 83:1996;251-254
30. Guan W., Osanai T., Kamada T., Ishizaka H., Hanada H., Okummara K. Time course of free radical production after primary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn. Circ. J. 63:1999;924-928
31. Walker P.M., Romaschin A.D., Davis S., Piovesan J. Lower limb ischemia. phase 1 results of salvage perfusion J. Surg. Res. 84:1999;193-198